Takeda CEO Signals Global Crises Could Force Drugmakers to Lower Prices
May 31, 2022
In a letter to shareholders sent Tuesday, May 31st, Takeda CEO Christophe Weber said that the escalating series of global crises may force drugmakers to reduce drug prices. As governments reel from the back-to-back impacts of the COVID-19 pandemic and energy shortages caused by Russia’s invasion of Ukraine, Weber predicts that they will tighten the screws on the industry, l
According to Weber, “Energy and food costs, together with supply chain constraints, have led to significantly higher inflation and economists are pointing to a heightened risk of a looming recession, particularly as the forces driving inflation show no signs of abating,”
To learn more, click here.
(Source: Seeking Alpha, May 31st 2022)